Related Experiment Video
Updated: Aug 10, 2025

10:35
Designing Microfluidic Devices for Studying Cellular Responses Under Single or Coexisting Chemical/Electrical/Shear Stress Stimuli
Published on: August 13, 2016
9.0K
Heterostructures with Built-in Electric Fields for Long-lasting Chemodynamic Therapy
Huilin Zhang1,2, Yang Chen3, Wei Hua1
1Departments of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, P. R. China.
Angewandte Chemie (International Ed. in English)
|February 13, 2023
Summary
Researchers developed a new catalyst for long-lasting chemodynamic therapy. This strategy uses a built-in electric field to sustainably generate hydroxyl radicals (⋅OH) for enhanced tumor treatment.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Sustained hydroxyl radical (⋅OH) generation is crucial for effective tumor treatment but remains a significant challenge.
- Chemodynamic therapy (CDT) offers a promising approach for cancer treatment by utilizing reactive oxygen species.
Purpose of the Study:
- To develop a strategy for sustainable generation of ⋅OH for long-lasting chemodynamic therapy (LCDT).
- To design and synthesize a novel Janus-like Fe@Fe3O4-Cu2O heterogeneous catalyst for enhanced ⋅OH production.
Main Methods:
- A built-in electric field (BIEF)-driven strategy was employed to facilitate continuous Fenton-like reactions.
- Synthesis of a Janus-like Fe@Fe3O4-Cu2O heterogeneous catalyst.
- Evaluation of ⋅OH release duration and antitumor efficacy in vitro and in vivo.
Main Results:
- The novel catalyst achieved sustained ⋅OH release for over 18 hours, significantly outperforming existing catalysts.
- Sustained ⋅OH levels led to persistent extracellular regulated protein kinases (ERK) signal activation in tumor cells.
- Demonstrated irreparable oxidative damage and irreversible tumor apoptosis in vitro and in vivo.
Conclusions:
- The BIEF-driven strategy enables sustainable ⋅OH generation for long-lasting chemodynamic therapy.
- The developed Janus-like Fe@Fe3O4-Cu2O catalyst shows significant potential for effective tumor treatment.
- This approach offers a promising platform for developing long-acting nanomedicines for various applications.

